SCHEDULE 13D

Company

Enveric Biosciences, Inc.

Filed

July 14, 2009

Accession Number

0001252699-09-000007

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →